Mechanisms of resistance to anti-EGFR therapy in colorectal cancer

Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy is effective for patients with RAS wild type metastatic colorectal cancer (mCRC). However, only a small percentage of mCRC patients are sensitive to anti-EGFR therapy and even the best cases finall...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ben, Wang, Lu, Qiu, Hong, Zhang, Mingsheng, Sun, Li, Peng, Ping, Yu, Qianqian, Yuan, Xianglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354808/
https://www.ncbi.nlm.nih.gov/pubmed/28002810
http://dx.doi.org/10.18632/oncotarget.14012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354808/
https://www.ncbi.nlm.nih.gov/pubmed/28002810
http://dx.doi.org/10.18632/oncotarget.14012

Ejemplares similares